Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Eric K. Nakakura is a pioneering surgical oncologist whose research and clinical practice are reshaping the standard of care for complex gastrointestinal and hepatobiliary malignancies. His work centers on advancing minimally invasive surgical techniques and developing personalized therapeutic strategies for challenging cancers. Dr. Nakakura is a leading voice in the adoption of minimally invasive distal pancreatectomy (MIDP), with his 2025 study critically evaluating its evolution as a potential standard of care in the US, accumulating 6 citations. He is at the forefront of precision oncology, as demonstrated by his 2020 research on patient-derived organoids for personalized drug screening in intrahepatic cholangiocarcinoma (ICC)—a disease with a dire prognosis and urgent need for novel therapies. Additionally, Dr. Nakakura has contributed innovative surgical solutions for benign tumors, such as his 2024 description of a robotic-assisted endoluminal technique for gastric leiomyoma resection at the gastroesophageal junction. Through these contributions, Dr. Nakakura is not only refining surgical approaches to improve patient outcomes but also pioneering the integration of personalized medicine into the treatment of rare and aggressive cancers.